Isabell Cordts, Ana Galhoz, Laura Tzeplaeff, Anne Gründel, Florian Kohlmayer, Andreas Schwersenz, Ines Marschalkowski, Bogdan Bjelica, Verena Panitz, Christian Schulze, Martin Svačina, Petra Rau, André C Dorigan, Marcus Deschauer, Simon Witzel, David Brenner, Jochen H Weishaupt, Sarah K Bublitz, Stefan Lorenzl, Andreas Hermann, Tim Hagenacker, Joachim Wolf, Martin Regensburger, Helmar C Lehmann, Maike F Dohrn, Johannes Dorst, René Guenther, André Maier, Thomas Meyer, Daniel Zeller, Christoph Neuwirth, Markus Weber, Jan C Koch, Matthias Boentert, Markus Weiler, Susanne Petri, Ute Weyen, Torsten Grehl, Michael P Menden, Paul Lingor
{"title":"EARLY-ALS: a multicentre study on prodromal amyotrophic lateral sclerosis.","authors":"Isabell Cordts, Ana Galhoz, Laura Tzeplaeff, Anne Gründel, Florian Kohlmayer, Andreas Schwersenz, Ines Marschalkowski, Bogdan Bjelica, Verena Panitz, Christian Schulze, Martin Svačina, Petra Rau, André C Dorigan, Marcus Deschauer, Simon Witzel, David Brenner, Jochen H Weishaupt, Sarah K Bublitz, Stefan Lorenzl, Andreas Hermann, Tim Hagenacker, Joachim Wolf, Martin Regensburger, Helmar C Lehmann, Maike F Dohrn, Johannes Dorst, René Guenther, André Maier, Thomas Meyer, Daniel Zeller, Christoph Neuwirth, Markus Weber, Jan C Koch, Matthias Boentert, Markus Weiler, Susanne Petri, Ute Weyen, Torsten Grehl, Michael P Menden, Paul Lingor","doi":"10.1016/j.ebiom.2026.106505","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Neurodegenerative diseases often feature a prolonged phase of subtle changes preceding diagnosis. In amyotrophic lateral sclerosis (ALS), defining this prodromal period is critical for identifying early disease features and intervention windows.</p><p><strong>Methods: </strong>In this case-control study, 475 patients with ALS and 285 controls from 20 centres in Germany and Switzerland completed a digital questionnaire on prodromal symptoms and health-related factors. Logistic regression included subgroup analyses by sex and clinical strata.</p><p><strong>Findings: </strong>Patients with ALS reported a higher burden of prodromal complaints (OR 7.50, 95% CI 4.27-13.17; P < 0.001), particularly neuro-motor, sensory, and pain-related symptoms. Before symptom onset, patients consulted neurologists more often (OR 1.26, 1.10-1.44; P < 0.001) and females more often received speech therapy (OR 2.35, 1.05-5.28; P = 0.038). Prodromal herniated discs were more common in males (OR 2.21, 1.04-4.68; P = 0.038) and spinal-onset patients (OR 2.14, 1.25-3.67; P = 0.006). Patients more often had lower secondary education (OR 1.93, 1.24-3.01; P = 0.004), physically demanding occupations (OR 2.21, 1.42-3.43; P < 0.001), and higher consumption habits (P < 0.005). Weight trajectories differed by sex (P = 0.009), with pre-onset weight loss in male patients (P < 0.001).</p><p><strong>Interpretation: </strong>Patients with ALS retrospectively reported subtle motor impairment before recognised symptom onset, alongside altered healthcare use and sex- and subgroup-specific patterns. These findings suggest that sporadic ALS may be preceded by a prodromal period and identify mild motor impairment as a potential marker, pending prospective validation.</p><p><strong>Funding: </strong>DGM e. V.</p>","PeriodicalId":11494,"journal":{"name":"EBioMedicine","volume":"133 ","pages":"106505"},"PeriodicalIF":11.2000,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13677275/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EBioMedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ebiom.2026.106505","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Neurodegenerative diseases often feature a prolonged phase of subtle changes preceding diagnosis. In amyotrophic lateral sclerosis (ALS), defining this prodromal period is critical for identifying early disease features and intervention windows.
Methods: In this case-control study, 475 patients with ALS and 285 controls from 20 centres in Germany and Switzerland completed a digital questionnaire on prodromal symptoms and health-related factors. Logistic regression included subgroup analyses by sex and clinical strata.
Findings: Patients with ALS reported a higher burden of prodromal complaints (OR 7.50, 95% CI 4.27-13.17; P < 0.001), particularly neuro-motor, sensory, and pain-related symptoms. Before symptom onset, patients consulted neurologists more often (OR 1.26, 1.10-1.44; P < 0.001) and females more often received speech therapy (OR 2.35, 1.05-5.28; P = 0.038). Prodromal herniated discs were more common in males (OR 2.21, 1.04-4.68; P = 0.038) and spinal-onset patients (OR 2.14, 1.25-3.67; P = 0.006). Patients more often had lower secondary education (OR 1.93, 1.24-3.01; P = 0.004), physically demanding occupations (OR 2.21, 1.42-3.43; P < 0.001), and higher consumption habits (P < 0.005). Weight trajectories differed by sex (P = 0.009), with pre-onset weight loss in male patients (P < 0.001).
Interpretation: Patients with ALS retrospectively reported subtle motor impairment before recognised symptom onset, alongside altered healthcare use and sex- and subgroup-specific patterns. These findings suggest that sporadic ALS may be preceded by a prodromal period and identify mild motor impairment as a potential marker, pending prospective validation.
EBioMedicineBiochemistry, Genetics and Molecular Biology-General Biochemistry,Genetics and Molecular Biology
CiteScore
17.70
自引率
0.90%
发文量
579
审稿时长
5 weeks
期刊介绍:
eBioMedicine is a comprehensive biomedical research journal that covers a wide range of studies that are relevant to human health. Our focus is on original research that explores the fundamental factors influencing human health and disease, including the discovery of new therapeutic targets and treatments, the identification of biomarkers and diagnostic tools, and the investigation and modification of disease pathways and mechanisms. We welcome studies from any biomedical discipline that contribute to our understanding of disease and aim to improve human health.